Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ARISE

Financiado

Cerrado

African Research and Innovative Initiative for Sickle cell Education Improving...

African Research and Innovative Initiative for Sickle cell Education Improving Research Capacity for Service Improvement The Overarching Objective for this consortium is to establish an inter-agency and multidisciplinary staff exchange programme between researchers, technical and administrative staff interaction within EU institutions as well as rea... ver más

31/10/2024

FONDAZIONE GIANNI...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 27 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-10-31

MSCA-RISE-2018: Research and Innovation Staff Excha...

I+D

Cerrada hace 6 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

27 Participantes

FONDAZIONE GIANNI BENZI ONLU...

147.20K€ | Lider

ICAR VISION SYSTEMS

282.79K€ | Participante

SCYTL SECURE ELECTRONIC VOTI...

458.86K€ | Participante

AOUP

N.D. | Participante

Proyectos interesantes

INNOVHEM

Medical Technol...

Data Science

75K€ Cerrado

HISCREENDIAG

Medical Technol...

Data Science

473K€ Cerrado

INVESTIGACIÓN E IDENTIFICACIÓN DE ALTERACIONE...

Medical Technol...

Data Science

577K€ Cerrado

EURO-GENE-SCAN

Medical Technol...

Data Science

4M€ Cerrado

ADGENTHE-CDA

Medical Technol...

Data Science

173K€ Cerrado

PRE2020-095361

Medical Technol...

Data Science

Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 72 meses Fecha Inicio: 2018-10-26
Fecha Fin: 2024-10-31

Líder del proyecto

FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The Overarching Objective for this consortium is to establish an inter-agency and multidisciplinary staff exchange programme between researchers, technical and administrative staff interaction within EU institutions as well as reaching out to non-EU countries in Africa, Lebanon and US in order to foster sharing of best practice in Newborn Screening, diagnosis and treatment of Sickle Cell Disease (SCD) leading to improvement in overall disease outcome. Using implementation science strategies for this consortium to foster partnerships and the establishment of patient database, registries and a sustainable service for people living with the disorder. Primary Objectives: - To evaluate the prevalence of sickle cell disease among populations in consortium member countries and identify specific haemoglobin genotypes and phenotypic presentations; - To establish laboratory diagnosis and quality assurance systems for population screening and setting up of SCD national prevention programmes; - To test the feasibility for establishing newborn and early infant screening for SCD in consortium participants; - To establish treatment protocols for common complications -acute and chronic pain, stroke, infections, severe anaemia as well as transition from paediatric to adult care, health promotion strategies and nutrition. In order to achieve these objectives, we designed the following WPs: Scientific Coordination and Project Management Implementing eHealth technologies to support a Newborn screening programme in EU, African Countries and Lebanon. Improving laboratory diagnosis and quality assurance systems for population screening. Newborn SCD screening, screening for neurocognitive complications, clinical care and antibiotic prophylaxis Enhancement of SCD management through training in molecular diagnostic techniques and Genetic Counseling for haemoglobinopathies and performance of epidemiological and Training in Research and academic leadership. Communication and dissemination

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores